These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9731777)

  • 1. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
    Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.
    LaPlante SR; Aubry N; Bonneau PR; Cameron DR; Lagacé L; Massariol MJ; Montpetit H; Plouffe C; Kawai SH; Fulton BD; Chen Z; Ni F
    Biochemistry; 1998 Jul; 37(27):9793-801. PubMed ID: 9657693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of human cytomegalovirus protease.
    Shieh HS; Kurumbail RG; Stevens AM; Stegeman RA; Sturman EJ; Pak JY; Wittwer AJ; Palmier MO; Wiegand RC; Holwerda BC; Stallings WC
    Nature; 1996 Sep; 383(6597):279-82. PubMed ID: 8805708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biochemical studies of inhibitor binding to human cytomegalovirus protease.
    Khayat R; Batra R; Qian C; Halmos T; Bailey M; Tong L
    Biochemistry; 2003 Feb; 42(4):885-91. PubMed ID: 12549906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.
    Batra R; Khayat R; Tong L
    Nat Struct Biol; 2001 Sep; 8(9):810-7. PubMed ID: 11524687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Bonneau PR; Cordingley MG; Lagacé L
    Nature; 1996 Sep; 383(6597):272-5. PubMed ID: 8805706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
    Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
    Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the induced-fit mechanism and catalytic activity of the human cytomegalovirus protease homodimer via molecular dynamics simulations.
    de Oliveira CA; Guimarães CR; Barreiro G; de Alencastro RB
    Proteins; 2003 Sep; 52(4):483-91. PubMed ID: 12910449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
    Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
    J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of HslUV complexed with a vinyl sulfone inhibitor: corroboration of a proposed mechanism of allosteric activation of HslV by HslU.
    Sousa MC; Kessler BM; Overkleeft HS; McKay DB
    J Mol Biol; 2002 May; 318(3):779-85. PubMed ID: 12054822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex.
    Hoog SS; Smith WW; Qiu X; Janson CA; Hellmig B; McQueney MS; O'Donnell K; O'Shannessy D; DiLella AG; Debouck C; Abdel-Meguid SS
    Biochemistry; 1997 Nov; 36(46):14023-9. PubMed ID: 9369473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.